Predictors of chronic opioid therapy in Medicaid beneficiaries with HIV who initiated antiretroviral therapy

Abstract The factors associated with chronic opioid therapy (COT) in patients with HIV is understudied. Using Medicaid data (2002–2009), this retrospective cohort study examines COT in beneficiaries with HIV who initiated standard combination anti-retroviral therapy (cART). We used generalized estim...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: GYeon Oh, Emily S. Brouwer, Erin L. Abner, David W. Fardo, Patricia R. Freeman, Chris Delcher, Daniela C. Moga
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/1dffd6870a4b4650b0f7b795bb0e5705
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1dffd6870a4b4650b0f7b795bb0e5705
record_format dspace
spelling oai:doaj.org-article:1dffd6870a4b4650b0f7b795bb0e57052021-12-02T18:47:10ZPredictors of chronic opioid therapy in Medicaid beneficiaries with HIV who initiated antiretroviral therapy10.1038/s41598-021-94690-82045-2322https://doaj.org/article/1dffd6870a4b4650b0f7b795bb0e57052021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94690-8https://doaj.org/toc/2045-2322Abstract The factors associated with chronic opioid therapy (COT) in patients with HIV is understudied. Using Medicaid data (2002–2009), this retrospective cohort study examines COT in beneficiaries with HIV who initiated standard combination anti-retroviral therapy (cART). We used generalized estimating equations on logistic regression models with backward selection to identify significant predictors of COT initiation. COT was initiated among 1014 out of 9615 beneficiaries with HIV (male: 10.4%; female: 10.7%). Those with older age, any malignancy, Hepatitis C infection, back pain, arthritis, neuropathy pain, substance use disorder, polypharmacy, (use of) benzodiazepines, gabapentinoids, antidepressants, and prior opioid therapies were positively associated with COT. In sex-stratified analyses, multiple predictors were shared between male and female beneficiaries; however, chronic obstructive pulmonary disease, liver disease, any malignancy, and antipsychotic therapy were unique to female beneficiaries. Comorbidities and polypharmacy were important predictors of COT in Medicaid beneficiaries with HIV who initiated cART.GYeon OhEmily S. BrouwerErin L. AbnerDavid W. FardoPatricia R. FreemanChris DelcherDaniela C. MogaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
GYeon Oh
Emily S. Brouwer
Erin L. Abner
David W. Fardo
Patricia R. Freeman
Chris Delcher
Daniela C. Moga
Predictors of chronic opioid therapy in Medicaid beneficiaries with HIV who initiated antiretroviral therapy
description Abstract The factors associated with chronic opioid therapy (COT) in patients with HIV is understudied. Using Medicaid data (2002–2009), this retrospective cohort study examines COT in beneficiaries with HIV who initiated standard combination anti-retroviral therapy (cART). We used generalized estimating equations on logistic regression models with backward selection to identify significant predictors of COT initiation. COT was initiated among 1014 out of 9615 beneficiaries with HIV (male: 10.4%; female: 10.7%). Those with older age, any malignancy, Hepatitis C infection, back pain, arthritis, neuropathy pain, substance use disorder, polypharmacy, (use of) benzodiazepines, gabapentinoids, antidepressants, and prior opioid therapies were positively associated with COT. In sex-stratified analyses, multiple predictors were shared between male and female beneficiaries; however, chronic obstructive pulmonary disease, liver disease, any malignancy, and antipsychotic therapy were unique to female beneficiaries. Comorbidities and polypharmacy were important predictors of COT in Medicaid beneficiaries with HIV who initiated cART.
format article
author GYeon Oh
Emily S. Brouwer
Erin L. Abner
David W. Fardo
Patricia R. Freeman
Chris Delcher
Daniela C. Moga
author_facet GYeon Oh
Emily S. Brouwer
Erin L. Abner
David W. Fardo
Patricia R. Freeman
Chris Delcher
Daniela C. Moga
author_sort GYeon Oh
title Predictors of chronic opioid therapy in Medicaid beneficiaries with HIV who initiated antiretroviral therapy
title_short Predictors of chronic opioid therapy in Medicaid beneficiaries with HIV who initiated antiretroviral therapy
title_full Predictors of chronic opioid therapy in Medicaid beneficiaries with HIV who initiated antiretroviral therapy
title_fullStr Predictors of chronic opioid therapy in Medicaid beneficiaries with HIV who initiated antiretroviral therapy
title_full_unstemmed Predictors of chronic opioid therapy in Medicaid beneficiaries with HIV who initiated antiretroviral therapy
title_sort predictors of chronic opioid therapy in medicaid beneficiaries with hiv who initiated antiretroviral therapy
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/1dffd6870a4b4650b0f7b795bb0e5705
work_keys_str_mv AT gyeonoh predictorsofchronicopioidtherapyinmedicaidbeneficiarieswithhivwhoinitiatedantiretroviraltherapy
AT emilysbrouwer predictorsofchronicopioidtherapyinmedicaidbeneficiarieswithhivwhoinitiatedantiretroviraltherapy
AT erinlabner predictorsofchronicopioidtherapyinmedicaidbeneficiarieswithhivwhoinitiatedantiretroviraltherapy
AT davidwfardo predictorsofchronicopioidtherapyinmedicaidbeneficiarieswithhivwhoinitiatedantiretroviraltherapy
AT patriciarfreeman predictorsofchronicopioidtherapyinmedicaidbeneficiarieswithhivwhoinitiatedantiretroviraltherapy
AT chrisdelcher predictorsofchronicopioidtherapyinmedicaidbeneficiarieswithhivwhoinitiatedantiretroviraltherapy
AT danielacmoga predictorsofchronicopioidtherapyinmedicaidbeneficiarieswithhivwhoinitiatedantiretroviraltherapy
_version_ 1718377608273461248